Cenrifki approved in EU for secondary progressive multiple sclerosis
23rd June 2026 Uncategorised 0
Sanofi therapy becomes first disability‑targeting medicine for nrSPMS

More: Cenrifki approved in EU for secondary progressive multiple sclerosis
Source: News
